← back to search

Sudhir Agrawal

University of Massachusetts Chan Medical School · US
Area of research
Molecular Biology · Immunology
Research interest
Research interests include Ipilimumab, Medicine, Melanoma, Internal medicine, Oncology, and Endoplasmic reticulum.
h-index
citations
104
works
2
NIH funding
primary concept
email

Recent publications

Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma
Cancer Discovery 2021cited by 69position: middledoi
Cutting Edge: The UNC93B1 Tyrosine-Based Motif Regulates Trafficking and TLR Responses via Separate Mechanisms
The Journal of Immunology 2014cited by 35position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2014–2014)Srinivas K. Chunduru · Tsinghua University1 papers (2021–2021)Tobias Schmidt · Lund University1 papers (2014–2014)Ann Marshak‐Rothstein · UMass Memorial Health Care1 papers (2014–2014)Montaser Shaheen · The University of Texas at San Antonio Health Science Center1 papers (2021–2021)Gary C. Doolittle · The University of Kansas Cancer Center1 papers (2021–2021) · 1 papers (2014–2014)Daniel H. Johnson · The University of Texas MD Anderson Cancer Center1 papers (2021–2021) · 1 papers (2014–2014) · 1 papers (2021–2021) · 1 papers (2021–2021)Nashat Gabrail · Gabrail Cancer Center1 papers (2021–2021)Denái R. Milton · The University of Texas MD Anderson Cancer Center1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Courtney W. Hudgens · The University of Texas MD Anderson Cancer Center1 papers (2021–2021)Eicke Latz · University Hospital Cologne1 papers (2014–2014)Veit Hornung · University of Massachusetts Chan Medical School1 papers (2014–2014) · 1 papers (2014–2014)Salah-Eddine Bentebibel · The University of Texas MD Anderson Cancer Center1 papers (2021–2021)